Overview

Target Publication: Outlier Today

The intersection of pharmaceutical innovation, intellectual property rights, and global public health presents one of the most critical bioethical dilemmas of our era. While patent protection guarantees R&D incentives for pharmaceutical companies, global supply chain inequalities often deprive other nations—particularly underdeveloped or developing countries—of timely access to life-saving vaccines. During major global health crises and epidemics, should these patents be temporarily waived (patent waiver), opened to compulsory licensing, or should property rights continue to be protected?

Submission Guidelines & Analytical Framework
Authors are encouraged to examine the core debate through one or more of the following analytical lenses (a broader, integrated perspective is highly recommended):

  • Ethical & Philosophical Frameworks
  • Economic & Innovation Incentives
  • Regional & Global Health Equity

Manuscript Specifications & Submission Requirements
Format: Opinions
Word Count: Submissions must be strictly between 250 and 400 words.
Call Reference Requirement: The official Call Number (e.g., CP-26003) must be explicitly indicated in the designated field of the submission template.